The "over 400 collectives" is a big deal. The name Medical Greens is fitting. Medical Greens, through the genius of Berkeley Bio, is emerging as a major player in advanced alternative-medicine output by deciphering and unlocking the phenomenal healing power of certain botanicals in order to address health issues that have stumped conventional medicine for decades and / or are very expensive to treat. The market is waiting for BB product to get to the collectives. Once the product stream begins to flow to end users, it's a good bet the stock price will not look back.